To provide an agent for preventing or treating periodontal disease, exhibiting high argingipain activity-inhibiting effects, and to provide an oral composition.
The agent for preventing or treating the periodontal disease comprises gabexate mesilate, and a water-soluble nonionic macromolecular material and/or a nonionic surfactant. The oral composition is obtained by formulating the gabexate mesilate, and the water-soluble nonionic macromolecular material and/or the nonionic surfactant. The agent for preventing or treating the periodontal disease exhibits the excellent argingipain activity-inhibiting effects by specifically inhibiting the argingipain of a cysteine protease produced by Porphyromonas gingivalis of a causative bacterium of the periodontal disease in high activity. The oral composition is useful for prevention or treatment of the periodontal disease.
JPN6012066511; 新化粧品ハンドブック , 20061030, 119-121
JPN6012066512; 今村隆寿: '歯周病菌Porphyromonas gingivalisトリプシン様システインプロテアーゼ(ジンジパイン)と炎症' 炎症と免疫 Vol.10, No.3, 200205, Page.239-246
JPN7012005225; 今日の治療薬(1996年版) , 199602, 653
Saori Shigematsu
Katsunari Kobayashi
Takeshi Ishikawa
Next Patent: SHEET FOR CLEANING SURROUNDING OF ANUS OR VAGINA